Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Bric-a-brac, Tramtrack, Broad-complex (BTB) domain is a protein-protein interaction domain that is found in many zinc finger transcription factors. BTB containing proteins play important roles in a variety of cellular functions including regulation of transcription, regulation of the cytoskeleton, protein ubiquitination, angiogenesis, and apoptosis. Here, we report the cloning and characterization of a novel human gene,
KLHL31
, from a human embryonic heart cDNA library. The cDNA of
KLHL31
is 5743 bp long, encoding a protein product of 634 amino acids containing a BTB domain. The protein is highly conserved across different species. Western blot analysis indicates that the
KLHL31
protein is abundantly expressed in both embryonic skeletal and heart tissue. In COS-7 cells,
KLHL31
proteins are localized to both the nucleus and the cytoplasm. In primary cultures of nascent mouse cardiomyocytes, the majority of endogenous
KLHL31
proteins are localized to the cytoplasm.
KLHL31
acts as a transcription repressor when fused to GAL4 DNA-binding domain and deletion analysis indicates that the BTB domain is the main region responsible for this repression. Overexpression of
KLHL31
in COS-7 cells inhibits the transcriptional activities of both the TPA-response element (TRE) and serum response element (SRE).
KLHL31
also significantly reduces JNK activation leading to decreased phosphorylation and protein levels of the JNK target c-Jun in both COS-7 and Hela cells. These results suggest that
KLHL31
protein may act as a new transcriptional repressor in MAPK/JNK signaling pathway to regulate cellular functions.
Mol
Cells 2008 Nov 30
PMID:A novel human BTB-kelch protein KLHL31, strongly expressed in muscle and heart, inhibits transcriptional activities of TRE and SRE. 1871 55
KLHL
and the related
KBTBD
genes encode components of the Cullin-E3 ubiquitin ligase complex and typically target tissue-specific proteins for degradation, thereby affecting differentiation, homeostasis, metabolism, cell signaling, and the oxidative stress response. Despite their importance in cell function and disease (especially,
KLHL40
,
KLHL41
,
KBTBD13
,
KEAP1
, and
ENC1
), previous studies of epigenetic factors that affect transcription were predominantly limited to promoter DNA methylation. Using diverse tissue and cell culture whole-genome profiles, we examined 17
KLHL
or
KBTBD
genes preferentially expressed in skeletal muscle or brain to identify tissue-specific enhancer and promoter chromatin, open chromatin (DNaseI hypersensitivity), and DNA hypomethylation. Sixteen of the 17 genes displayed muscle- or brain-specific enhancer chromatin in their gene bodies, and most exhibited specific intergenic enhancer chromatin as well. Seven genes were embedded in super-enhancers (particularly strong, tissue-specific clusters of enhancers). The enhancer chromatin regions typically displayed foci of DNA hypomethylation at peaks of open chromatin. In addition, we found evidence for an intragenic enhancer in one gene upregulating expression of its neighboring gene, specifically for
KLHL40
/
HHATL
and
KLHL38/FBXO32
gene pairs. Many
KLHL/KBTBD
genes had tissue-specific promoter chromatin at their 5' ends, but surprisingly, two (
KBTBD11
and
KLHL31
) had constitutively unmethylated promoter chromatin in their 3' exons that overlaps a retrotransposed
KLHL
gene. Our findings demonstrate the importance of expanding epigenetic analyses beyond the 5' ends of genes in studies of normal and abnormal gene regulation.
Int J
Mol
Sci 2020 Nov 09
PMID:Epigenetics of Muscle- and Brain-Specific Expression of KLHL Family Genes. 3318 25